Jounce Therapeutics, Inc. (JNCE) Social Stream
JOUNCE THERAPEUTICS INC (JNCE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering JNCE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-11 | 6 | $17 | $15 | $15.5 | $1.88 | 724.47% |
| 2022-03-08 | 6 | $17 | $15 | $15.5 | $1.88 | 724.47% |
| 2022-03-16 | 7 | $17 | $15 | $15.8 | $1.88 | 740.43% |
| 2022-05-05 | 7 | $17 | $15 | $15.8 | $1.88 | 740.43% |
| 2022-05-06 | 7 | $20 | $15 | $16.8 | $1.88 | 793.62% |
| 2022-05-12 | 8 | $20 | $7 | $15.166 | $1.88 | 706.7% |
| 2022-05-23 | 7 | $20 | $7 | $13.6 | $1.88 | 623.4% |
| 2022-08-04 | 6 | $20 | $7 | $13.6 | $1.88 | 623.4% |
| 2022-08-05 | 6 | $20 | $7 | $12.8 | $1.88 | 580.85% |
| 2022-08-31 | 6 | $17 | $6 | $11.4 | $1.88 | 506.38% |
| 2022-11-15 | 6 | $17 | $3 | $8.8 | $1.88 | 368.09% |
| 2023-01-03 | 6 | $17 | $3 | $8.6 | $1.88 | 357.45% |
| 2023-03-15 | 3 | $17 | $5 | $9.666 | $1.88 | 414.15% |
| 2023-03-27 | 3 | $7 | $1.85 | $4.425 | $1.88 | 135.37% |
The Trend in the Analyst Price Target
Over the past 136 days, JNCE's average price target has gone down $4.38.
JNCE reports an average of 478.06% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-23 | 7 | 20 | 7 | 13.600 | 4.65 | 192.47% |
| 2023-01-03 | 4 | 17 | 5 | 9.666 | 1.09 | 786.79% |
| 2023-01-03 | 3 | 17 | 5 | 10.000 | 1.09 | 817.43% |
| 2023-01-03 | 6 | 17 | 3 | 8.600 | 1.09 | 688.99% |
| 2023-01-03 | 3 | 17 | 5 | 9.666 | 1.09 | 786.79% |
JNCE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 3 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 13 months, JNCE's average broker recommendation rating worsened by 1.17.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- JOUNCE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1651.05% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, JOUNCE THERAPEUTICS INC's average analyst price target is higher than 248.1% of them.
- To contextualize these metrics, consider that out of all US stocks, JOUNCE THERAPEUTICS INC's variance in analysts' estimates is lower than -1110.68% of them.
- JNCE has a higher number of analysts covering the stock than 1224.68% of stocks in the small market cap category.
Stocks similar to JOUNCE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADAP, OTLK, and TTNP.
View All Top Stocks by Price Target
Is JNCE a Buy, Hold or Sell? See the POWR Ratings now!